PDE5A and arterial occlusive disease: Nightly treatment with a PDE5 inhibitor has also been shown to be effective in enhancing EF in patients with arteriogenic ED (141); many patients with inadequate responses to PDE5 inhibitors after prostatectomy have arterial insufficiency (142,143).